Cargando…

Neoantigen landscape in metastatic nasopharyngeal carcinoma

Background: Reportedly, nasopharyngeal carcinoma (NPC) patients with MHC I Class aberration are prone to poor survival outcomes, which indicates that the deficiency of tumor neoantigens might represent a mechanism of immune surveillance escape in NPC. Methods: To clearly delineate the landscape of n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Mei, Zhang, Xiao-Long, You, Rui, Yang, Qi, Zou, Xiong, Yu, Kai, Liu, You-Ping, Zou, Ru-Hai, Hua, Yi-Jun, Huang, Pei-Yu, Wang, Jin, Zhao, Qi, Jiang, Xiao-Bing, Tang, Jun, Gu, Yang-Kui, Yu, Tao, He, Gui-Ping, Xie, Yu-Long, Wang, Zhi-Qiang, Liu, Ting, Chen, Si-Yuan, Zuo, Zhi-Xiang, Chen, Ming-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120206/ https://www.ncbi.nlm.nih.gov/pubmed/33995666 http://dx.doi.org/10.7150/thno.53229

Ejemplares similares

Biopsy of distant metastasis is not a significant prognostic factor for synchronous metastatic nasopharyngeal carcinoma: a propensity score-matched analysis from the Surveillance Epidemiology and End-Results Registry
por: Lin, Mei, et al.
Publicado: (2021)

Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance
por: Lin, Mei, et al.
Publicado: (2023)

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study
por: Ding, Xi, et al.
Publicado: (2023)

A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma
por: Zou, Xiong, et al.
Publicado: (2018)

Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study
por: Zhang, Meng-Xia, et al.
Publicado: (2022)

Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial
por: Chen, Si-Yuan, et al.
Publicado: (2023)

Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
por: Liu, You-Ping, et al.
Publicado: (2019)

The Clinical Application of Neoantigens in Esophageal Cancer
por: Gu, Yi-Min, et al.
Publicado: (2021)

The Neoantigen Landscape of Mycosis Fungoides
por: Sivanand, Arunima, et al.
Publicado: (2020)

The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
por: Zhi-Qiang, Wang, et al.
Publicado: (2019)

Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study
por: Ding, Xi, et al.
Publicado: (2023)

The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
por: Wei, Zhiting, et al.
Publicado: (2019)

Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells
por: Ma, Fei, et al.
Publicado: (2020)

NeoPeptide: an immunoinformatic database of T-cell-defined neoantigens
por: Zhou, Wei-Jun, et al.
Publicado: (2019)

Likelihood Ratio Test for Excess Homozygosity at Marker Loci on X Chromosome
por: You, Xiao-Ping, et al.
Publicado: (2015)

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
por: Wang, Wenwen, et al.
Publicado: (2022)

Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma in vitro
por: Yang, Yang, et al.
Publicado: (2022)

Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy–Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial
por: Yang, Qi, et al.
Publicado: (2023)

Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
por: Leng, Qibin, et al.
Publicado: (2020)

LENS: Landscape of Effective Neoantigens Software
por: Vensko, Steven P, et al.
Publicado: (2023)

Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Mao, Yan-Ping, et al.
Publicado: (2016)

Adding Concurrent Chemotherapy Significantly Improves the Survival of Stage II-IVb Nasopharyngeal Carcinoma Patients Treated With Concurrent Anti-EGFR Agents
por: Yu, Zi-Kun, et al.
Publicado: (2021)

Overexpression of Notch2 enhances radiosensitivity via inhibition of the AKT/mTOR signaling pathway in nasopharyngeal carcinoma
por: Wu, Li-Zhi, et al.
Publicado: (2021)

The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis
por: You, Rui, et al.
Publicado: (2017)

A powerful parent-of-origin effects test for qualitative traits on X chromosome in general pedigrees
por: Zou, Qi-Lei, et al.
Publicado: (2018)

Nasopharyngeal carcinoma incidence and mortality in China in 2009
por: Xu, Zhi-Jian, et al.
Publicado: (2013)

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy
por: Lv, Jia‐Wei, et al.
Publicado: (2018)

Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up
por: You, Rui, et al.
Publicado: (2017)

DNA storage: research landscape and future prospects
por: Dong, Yiming, et al.
Publicado: (2020)

Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities
por: Guo, Rui, et al.
Publicado: (2015)

Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology
por: Wang, Ya-Qin, et al.
Publicado: (2020)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
por: Zou, Xue-lin, et al.
Publicado: (2021)

Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer
por: Yang, Hua, et al.
Publicado: (2022)

The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
por: Peng, Liang, et al.
Publicado: (2019)

Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer
por: Yu, Yao-Jun, et al.
Publicado: (2023)

Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
por: Tao, Chang-Juan, et al.
Publicado: (2013)

Ultrasound-guided fine needle aspiration of retropharyngeal lymph nodes after radiotherapy for nasopharyngeal carcinoma: a novel technique for accurate diagnosis
por: He, Long-Jun, et al.
Publicado: (2018)

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
por: Pang, Zhi, et al.
Publicado: (2023)

High expression of Sox10 correlates with tumor aggressiveness and poor prognosis in human nasopharyngeal carcinoma
por: Zhao, Yu, et al.
Publicado: (2016)

Characterization of the immune cell infiltration landscape in myxofibrosarcoma to aid immunotherapy
por: Zhao, Zi-Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6u1b3r7gp0mmkvlu1ul74iu7bu